1887

oa SA Pharmaceutical Journal - New drug focus : drug info

 

Abstract

Oxybutynin has been well-established as an effective treatment option for symptoms of OAB. The advantages of the OROS® formulation of oxybutynin over the immediate-release formulation are its ease of use due to once daily administration and an improved tolerability profile.

Loading

Article metrics loading...

/content/mp_sapj/75/9/EJC82044
2008-10-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error